Details

Autor(en) / Beteiligte

• Sőnksen, Peter H
• Bavington, L Dawn
• Boehning, Tan
• Cowan, David
• Guha, Nishan
• Holt, Richard
• Karkazis, Katrina
• Ferguson-Smith, Malcolm Andrew
• Mircetic, Jovan
• Bőhning, Dankmar

Titel

Hyperandrogenism controversy in elite women’s sport: an examination and critique of recent evidence

Ist Teil von

• British journal of sports medicine, 2018-12, Vol.52 (23), p.1481-1482

Ort / Verlag

England: BMJ Publishing Group LTD

Erscheinungsjahr

2018

Quelle

MEDLINE

Beschreibungen/Notizen

• Correspondence to Professor Peter H Sőnksen, East Wing Preshaw House, Preshaw, Southampton, Southampton SO32 1HP, UK; PHSonksen@aol.com The limitations of a cross-sectional study design In July 2017, the International Association of Athletics Federations (IAAF) was expected to return to the Court of Arbitration for Sport (CAS) with evidence to justify reinstatement of their controversial hyperandrogenism rule. Initial burden: male typical advantage The IAAF was tasked by CAS with providing sufficient evidence that female athletes with androgen levels in the so-called male range have a competitive advantage over their peers, comparable to that men have over women, previously identified as 10%–12% [2; Para 526]. The IAAF acknowledged this fact in their previous study to determine whether unusually high levels of testosterone in women provide a competitive advantage, which used the same data from the 2011 World Athletic Championships in Daegu.6 They stated that they were unable to exclude other variables that ‘…in some unknown way may bring an advantage to female athletes’ (see also Ferguson-Smith and Bavington7).